Objective The aims of this study were to evaluate health outcomes and the economic burden
of hospitalized COVID-19 patients in the United States. Methods Hospitalized patients with …

This cohort analysis investigated the prevalence of nonalcoholic fatty liver disease (NAFLD)
and NAFLD with fibrosis at different stages, associated clinical characteristics, and …

Background The COVID-19 pandemic, caused by the novel severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), has substantially impacted healthcare utilization worldwide…

Background Little is known about the relationship between coronavirus disease 2019 (COVID-19)
severity and subsequent risk of experiencing a cardiovascular event (CVE) after …

… McGrath LJ, Scott AM, Surinach A, Chambers R, Benigno M, Malhotra D. Use of the
Postacute … Ms Malhotra reported being employed by and holding stock in Pfizer, Inc. No other …

Objective To evaluate COVID-19 vaccine breakthrough infections among immunocompromised
(IC) individuals. Methods Individuals vaccinated with BNT162b2 were selected from the …

This study describes demographics, thrombotic and bleeding events, mortality, and
anticoagulant use among hospitalized patients with COVID-19 in the United States. Premier …

Purpose Osteoarthritis (OA) is one of the most common causes of chronic pain and a leading
cause of disability in the US. The objective of this study was to examine the clinical and …

Objectives To describe the characteristics, healthcare resource use and costs associated with
initial hospitalization and readmissions among pediatric patients with COVID-19 in the US. …

Background Several underlying medical conditions have been reported to be associated with
an increased risk of coronavirus disease 2019 (COVID-19) and related hospitalization and …